These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6371810)

  • 1. Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2.
    Altman A; Cardenas JM; Houghten RA; Dixon FJ; Theofilopoulos AN
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2176-80. PubMed ID: 6371810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staining and fluorescence-activated cell sorter analysis of human lymphocytes using antibodies to a short, chemically synthesized human IL-2 peptide.
    Isakov N; Fox RI; Dixon FJ; Theofilopoulos AN; Altman A
    Cell Immunol; 1985 Sep; 94(2):491-9. PubMed ID: 3896523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid phase enzyme immunoassay of human interleukin 2 utilizing antibodies against synthetic IL-2 peptides.
    Jandlová T; Bubeník J; Krchnák V; Vágner J; Voitenok NN; Gren E; Símová J; Mach O
    Folia Biol (Praha); 1989; 35(4):207-17. PubMed ID: 2691283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2.
    Fox RI; Theofilopoulos AN; Altman A
    J Immunol; 1985 Nov; 135(5):3109-15. PubMed ID: 3876375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of anti-peptide antibodies for the localization of D2 dopamine receptors in rat striatum.
    McVittie LD; Ariano MA; Sibley DR
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1441-5. PubMed ID: 1825357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.
    Smith KA; Favata MF; Oroszlan S
    J Immunol; 1983 Oct; 131(4):1808-15. PubMed ID: 6352804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin 1.
    Rao KV; Nayak AR
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5519-22. PubMed ID: 2371286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and immunochemical properties of peptides corresponding to sequences 59-72 and 25-36 of human interleukin-2].
    Onoprienko LV; Mikhaleva II; Lunev VE; Nesmeianov VA; Ivanov VT
    Bioorg Khim; 1989 Jul; 15(7):908-21. PubMed ID: 2818650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids.
    Alexander H; Johnson DA; Rosen J; Jerabek L; Green N; Weissman IL; Lerner RA
    Nature; 1983 Dec 15-21; 306(5944):697-9. PubMed ID: 6656870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
    Partidos C; Stanley C; Steward M
    Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and application of a polyclonal antibody against the peptides of β₂glycoprotein 1].
    Xie H; Zhou H; Kong X; Xie Y; Cheng S; Yu Y; Xia L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):402-7. PubMed ID: 25744848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of a monoclonal antibody against human IL-2 and its application for IL-2 measurement.
    Brandt E; Ulmer AJ; Flad HD
    Lymphokine Res; 1986; 5 Suppl 1():S35-42. PubMed ID: 3491262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
    Bamford RN; Grant AJ; Burton JD; Peters C; Kurys G; Goldman CK; Brennan J; Roessler E; Waldmann TA
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4940-4. PubMed ID: 8197161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.
    Jacob CO; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7611-5. PubMed ID: 6584874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3.
    Ziltener HJ; Clark-Lewis I; Hood LE; Kent SB; Schrader JW
    J Immunol; 1987 Feb; 138(4):1099-104. PubMed ID: 2433340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.